Sangamo Therapeutics
SGMO
SGMO
121 hedge funds and large institutions have $34.5M invested in Sangamo Therapeutics in 2025 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 33 increasing their positions, 33 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
21% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 28
45% less capital invested
Capital invested by funds: $62.9M → $34.5M (-$28.4M)
Holders
121
Holding in Top 10
–
Calls
$1.77M
Puts
$1.84M
Top Buyers
| 1 | +$1,000K | |
| 2 | +$692K | |
| 3 | +$613K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$364K |
| 5 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
+$222K |
Top Sellers
| 1 | -$2.56M | |
| 2 | -$1.55M | |
| 3 | -$1.1M | |
| 4 |
Millennium Management
New York
|
-$1.03M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$755K |